NPI: 1730330440 · CANTON, OH 44708 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 10/01/2008
Authorized official WINSTEL, JOHN controls 20+ related entities in our dataset. Read more
| Authorized Official | WINSTEL, JOHN (CHIEF ACCOUNTING OFFICER) |
| NPI Enumeration Date | 10/01/2008 |
Other providers sharing the same authorized official: WINSTEL, JOHN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 19,522 | $258K |
| 2019 | 11,371 | $183K |
| 2020 | 2,278 | $113K |
| 2021 | 3,053 | $268K |
| 2022 | 2,514 | $237K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 16,526 | 1,211 | $1.02M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 10,684 | 493 | $34K |
| J1756 | Injection, iron sucrose, 1 mg | 2,234 | 413 | $6K |
| J1270 | Injection, doxercalciferol, 1 mcg | 6,024 | 362 | $1K |
| 83970 | 179 | 127 | $232.05 | |
| 83550 | 511 | 358 | $123.27 | |
| 83540 | 512 | 357 | $91.29 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 31 | 13 | $53.62 |
| 82728 | 162 | 115 | $46.35 | |
| 82108 | 36 | 20 | $37.08 | |
| 85041 | 330 | 244 | $37.04 | |
| 85048 | 328 | 242 | $28.32 | |
| 90674 | 18 | 14 | $24.05 | |
| G0008 | Administration of influenza virus vaccine | 16 | 13 | $7.50 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 35 | 24 | $4.61 |
| A4657 | Syringe, with or without needle, each | 1,112 | 471 | $2.84 |